The Covid-19 Vaccine Revolution
TAU Professor Jonathan Gershoni tells the story of the significant scientific landmarks that led to the creation of RNA vaccines, that are significant in the global battle against the pandemic.
TAU researchers identify coronavirus proteins that can damage blood vessels
A team of experts led by Tel Aviv University (TAU) has identified five of the 29 proteins in the coronavirus that are responsible for damaging blood vessels. The researchers hope that the identification of these proteins will help develop targeted drugs for COVID-19 that reduce vascular damage. The study was led by Dr. Ben Maoz… Read More
Study from TAU identifies differing levels of COVID-19 antibodies in men and women
A joint study conducted by researchers from Tel Aviv University (TAU) and the Shamir Medical Center (Asaf Harofe) indicates that the level of COVID-19 antibodies in the human blood stream differs according to age groups, gender, symptoms, and time elapsed since vaccination. The research examined the level of antibodies in over 26,000 blood samples taken… Read More
Sick bats use “social distancing” to prevent the outbreak of epidemics
The Covid-19 pandemic led to expressions like “lockdown,” “isolation,” and “social distancing” becoming part of social conduct all over the world. Now it appears that bats also maintain social distancing, which might help prevent the spread of contagious diseases in their colonies. In a new study published in the Annals of the New York Academy… Read More
TAU research finds British variant of COVID-19 is 45% more contagious than the original virus
A new study from Tel Aviv University (TAU) found that the British variant of the COVID-19 virus (B.1.1.7) is 45% more contagious than the original virus. The researchers relied on data from about 300,000 PCR tests for COVID-19 obtained from the COVID-19 testing lab established by TAU in collaboration with the Electra Group. The new… Read More
TAU study finds COVID-19 vaccine less effective against the South African variant compared to British variant
Tel Aviv University and Clalit Research Institute researchers have found that the South African variant of the COVID-19 virus is significantly more likely to break through the protective effect of two doses of the Pfizer vaccine compared to the British COVID-19 variant. Researchers say that the exact reduction in effectiveness cannot be accurately assessed from… Read More
COVID-19 vaccinations for breastfeeding mothers may help protect their nursing babies
A new study conducted jointly by Tel Aviv University and the Tel Aviv Sourasky Medical Center–Ichilov found that vaccinating breastfeeding mothers promotes the production of important antibodies in their breast milk, potentially contributing to the protection of their nursing babies. The leading team at TAU included Dr. Yariv Wine and PhD student Aya Kigel from… Read More
Global First: Center for Combating Pandemics
Despite tens of millions of cases worldwide and rising, SARS-Cov-2, the new coronavirus also referred to as COVID-19, remains largely misunderstood. The scientific and medical communities still do not know the causes – or long-term effects – of the killer virus’s wide range of symptoms. As more and more countries, including Israel, experience a second… Read More